Ovarian cancer early detection and prevention. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

Cell Line, Tumor Tumor Cells, Cultured Ovary Neoplastic Stem Cells Epithelial Cells Breast

Organisms3

Mice, Nude Mice, Inbred BALB C Mice, SCID

Diseases52

Uterine Cervical Neoplasms Ovarian Neoplasms Breast Neoplasms Neoplasms, Glandular and Epithelial Cystadenocarcinoma, Serous Carcinoma Neoplasms Prostatic Neoplasms Neoplasm Invasiveness Lung Neoplasms Adenocarcinoma, Clear Cell Genetic Predisposition to Disease Neoplasm Metastasis Adenocarcinoma, Mucinous Carcinoma, Endometrioid Disease Progression Colonic Neoplasms Peritoneal Neoplasms Stomach Neoplasms Ascites Pancreatic Neoplasms Neoplasm Recurrence, Local Colorectal Neoplasms Endometrial Neoplasms Adenocarcinoma Carcinoma, Squamous Cell Cystadenocarcinoma Precancerous Conditions Fallopian Tube Neoplasms Cell Transformation, Neoplastic Urinary Bladder Neoplasms Mouth Neoplasms Genital Neoplasms, Female Neoplasms, Cystic, Mucinous, and Serous Carcinoma, Non-Small-Cell Lung Neoplastic Syndromes, Hereditary Disease Models, Animal Skin Neoplasms Neovascularization, Pathologic Hereditary Breast and Ovarian Cancer Syndrome Liver Neoplasms Cystadenocarcinoma, Mucinous Esophageal Neoplasms Rectal Neoplasms Melanoma Neoplasms, Second Primary Recurrence Head and Neck Neoplasms Cystadenoma, Serous Neoplasms, Multiple Primary HIV Infections Carcinoma in Situ

Chemicals and Drugs43

CA-125 Antigen Tumor Markers, Biological Antineoplastic Agents Neoplasm Proteins Cisplatin Paclitaxel BRCA2 Protein BRCA1 Protein Epididymal Secretory Proteins RNA, Messenger DNA, Neoplasm Antineoplastic Agents, Phytogenic Carboplatin Antigens, Neoplasm Cancer Vaccines Antibodies, Monoclonal RNA, Small Interfering Prostate-Specific Antigen Tumor Suppressor Protein p53 DNA Primers Biological Markers Receptor, erbB-2 Platinum Platinum Compounds Antigens, Tumor-Associated, Carbohydrate Receptors, Estrogen MicroRNAs RNA, Neoplasm Tumor Suppressor Proteins Anticarcinogenic Agents Topotecan Transcription Factors Receptor, Epidermal Growth Factor DNA-Binding Proteins Taxoids Proto-Oncogene Proteins Genetic Markers Tamoxifen Receptors, Progesterone Nuclear Proteins Mucin-1 Carcinoembryonic Antigen Antibiotics, Antineoplastic

Analytical, Diagnostic and Therapeutic Techniques and Equipment83

Early Detection of Cancer Mammography Mass Screening Vaginal Smears Early Diagnosis Sensitivity and Specificity Risk Factors Prognosis Polymerase Chain Reaction Neoplasm Staging Reproducibility of Results Reverse Transcriptase Polymerase Chain Reaction Prospective Studies Survival Analysis Retrospective Studies Follow-Up Studies Risk Assessment Survival Rate Gene Expression Profiling Antineoplastic Combined Chemotherapy Protocols Predictive Value of Tests Xenograft Model Antitumor Assays Risk Incidence Limit of Detection Case-Control Studies Treatment Outcome Immunohistochemistry Genetic Testing Blotting, Western Enzyme-Linked Immunosorbent Assay ROC Curve Oligonucleotide Array Sequence Analysis Questionnaires Disease-Free Survival Odds Ratio Registries Neoplasm Transplantation Cohort Studies Multivariate Analysis Immunoenzyme Techniques Combined Modality Therapy Logistic Models Kaplan-Meier Estimate Clinical Trials as Topic Prevalence False Positive Reactions Breast Self-Examination DNA Mutational Analysis Transplantation, Heterologous Immunoassay Tissue Array Analysis Neoplasm Grading Biopsy Flow Cytometry Drug Screening Assays, Antitumor Disease Models, Animal Tumor Burden Evaluation Studies as Topic Models, Biological Confidence Intervals Pilot Projects Transfection Self-Examination Drug Administration Schedule Real-Time Polymerase Chain Reaction Chemotherapy, Adjuvant Tomography, X-Ray Computed SEER Program Feasibility Studies Population Surveillance Cross-Sectional Studies Cluster Analysis Molecular Diagnostic Techniques False Negative Reactions Diagnostic Imaging Protein Array Analysis Molecular Targeted Therapy Gene Knockdown Techniques Positron-Emission Tomography Sequence Analysis, DNA Chemoprevention Salpingectomy

Psychiatry and Psychology5

Smoking Breast Self-Examination Self-Examination Health Knowledge, Attitudes, Practice Preventive Psychiatry

Phenomena and Processes44

Sensitivity and Specificity Genes, BRCA1 Gene Expression Regulation, Neoplastic Drug Resistance, Neoplasm Genes, BRCA2 Genetic Predisposition to Disease Time Factors Mutation Risk DNA Methylation Germ-Line Mutation Cell Proliferation Apoptosis Genotype Odds Ratio Base Sequence Algorithms Cell Survival Dose-Response Relationship, Drug Signal Transduction Down-Regulation Genes, Tumor Suppressor Cell Movement Promoter Regions, Genetic Up-Regulation Cell Division Cell Growth Processes Polymorphism, Genetic Heterozygote Cell Cycle Transfection Gene Expression Pregnancy Gene Silencing RNA Interference Diet Phenotype Genes, Neoplasm Alleles Genetic Markers Drug Synergism Gene Amplification Epigenesis, Genetic Genes, p53

Disciplines and Occupations5

Immunohistochemistry Medical Oncology Proteomics Genetic Counseling Preventive Psychiatry

Anthropology, Education, Sociology and Social Phenomena5

Centers for Disease Control and Prevention (U.S.)National Cancer Institute (U.S.)Health Education Age Distribution Quality of Life

Humanities1

Quality of Life

Information Science9

Survival Rate Incidence Questionnaires Registries Molecular Sequence Data Base Sequence Algorithms Prevalence SEER Program

Named Groups5

Medically Uninsured Survivors Infant, Newborn Jews European Continental Ancestry Group

Health Care49

Mass Screening Sensitivity and Specificity Risk Factors Primary Prevention Reproducibility of Results Prospective Studies Survival Analysis Retrospective Studies Follow-Up Studies Risk Assessment Survival Rate Predictive Value of Tests Risk Incidence Limit of Detection Case-Control Studies Age Factors Treatment Outcome Genetic Testing ROC Curve Questionnaires Disease-Free Survival Odds Ratio Registries Centers for Disease Control and Prevention (U.S.)Cohort Studies Multivariate Analysis Logistic Models Secondary Prevention Kaplan-Meier Estimate Clinical Trials as Topic Prevalence National Cancer Institute (U.S.)Evaluation Studies as Topic Confidence Intervals Pilot Projects Genetic Counseling SEER Program Feasibility Studies Population Surveillance Cross-Sectional Studies Cluster Analysis Health Education American Cancer Society Age Distribution Health Knowledge, Attitudes, Practice Accident Prevention Health Promotion Practice Guidelines as Topic

Geographicals3

United States China Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Early Detection of Cancer Mammography Uterine Cervical Neoplasms Ovarian Neoplasms Mass Screening Medically Uninsured Breast Neoplasms Vaginal Smears United States Neoplasms, Glandular and Epithelial Early Diagnosis Sensitivity and Specificity CA-125 Antigen Tumor Markers, Biological Cystadenocarcinoma, Serous Cell Line, Tumor Genes, BRCA1 Gene Expression Regulation, Neoplastic Risk Factors Prognosis Carcinoma Neoplasms Primary Prevention Polymerase Chain Reaction Neoplasm Staging Antineoplastic Agents Prostatic Neoplasms Mice, Nude Drug Resistance, Neoplasm Neoplasm Invasiveness Reproducibility of Results Lung Neoplasms Genes, BRCA2 Neoplasm Proteins Reverse Transcriptase Polymerase Chain Reaction Cisplatin Prospective Studies Adenocarcinoma, Clear Cell Paclitaxel Genetic Predisposition to Disease Survival Analysis Time Factors BRCA2 Protein Neoplasm Metastasis Retrospective Studies Adenocarcinoma, Mucinous Follow-Up Studies Carcinoma, Endometrioid Disease Progression BRCA1 Protein Colonic Neoplasms Risk Assessment Mutation Survival Rate Gene Expression Profiling Epididymal Secretory Proteins Peritoneal Neoplasms Antineoplastic Combined Chemotherapy Protocols Predictive Value of Tests Stomach Neoplasms Xenograft Model Antitumor Assays Ascites Risk Pancreatic Neoplasms Incidence Limit of Detection Neoplasm Recurrence, Local RNA, Messenger Case-Control Studies Age Factors DNA, Neoplasm DNA Methylation Treatment Outcome Immunohistochemistry Tumor Cells, Cultured Genetic Testing Colorectal Neoplasms Germ-Line Mutation Blotting, Western Cell Proliferation Enzyme-Linked Immunosorbent Assay ROC Curve Oligonucleotide Array Sequence Analysis Apoptosis Questionnaires Disease-Free Survival Endometrial Neoplasms Antineoplastic Agents, Phytogenic Carboplatin Adenocarcinoma Carcinoma, Squamous Cell Antigens, Neoplasm Genotype Odds Ratio Cystadenocarcinoma Registries Neoplasm Transplantation Precancerous Conditions Centers for Disease Control and Prevention (U.S.)Ovary

No FAQ available that match "ovarian cancer early detection and prevention"